Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (361-370 of 455) with videos related to

Pageof 46
Sort By:
Diabetes Care|January 18, 2020
No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 DiabetesNatasha C Bergmann, Lærke S Gasbjerg, Sebastian M Heimbürger, et al.
Thrombosis Journal|June 25, 2024
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort studyHans Johan Niklas Lorentsson, Christina R Clausen, Daniel Faurholt-Jepsen, et al.
Diabetologia|September 27, 2017
GIP(3-30)NH<sub>2</sub> is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover studyLærke S Gasbjerg, Mikkel B Christensen, Bolette Hartmann, et al.
European Journal of Endocrinology|November 18, 2024
Secretin infusion decreases food intake in healthy men-a randomized, placebo-controlled, double-blind, crossover studySebastian M N Heimbürger, Maria J Bentzen, Hüsün S Kizilkaya, et al.
Diabetologia|April 2, 2017
Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effectSigne Foghsgaard, Louise Vedtofte, Camilla Andreasen, et al.
Diabetes, Obesity & Metabolism|March 2, 2018
Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamerAndreas Brønden, Kristian Mikkelsen, David P Sonne, et al.
European Journal of Endocrinology|June 4, 2021
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controlsAndreas Andersen, Jonatan I Bagger, Maria P A Baldassarre, et al.
Diabetes|May 5, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover StudyNikolaj E Sørum, Julie Warnøe, Jens J Holst, et al.
Diabetes, Obesity & Metabolism|September 7, 2018
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysisDan Siskind, Margaret Hahn, Christoph U Correll, et al.
Cell Reports. Medicine|May 2, 2022
LEAP2 reduces postprandial glucose excursions and <i>ad libitum</i> food intake in healthy menChristoffer A Hagemann, Malene S Jensen, Stephanie Holm, et al.
Pageof 46

Showing results (361-370 of 455) with videos related to

Sort By:
Pageof 46
Diabetes Care|January 18, 2020
No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 DiabetesNatasha C Bergmann, Lærke S Gasbjerg, Sebastian M Heimbürger, et al.
Thrombosis Journal|June 25, 2024
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort studyHans Johan Niklas Lorentsson, Christina R Clausen, Daniel Faurholt-Jepsen, et al.
Diabetologia|September 27, 2017
GIP(3-30)NH<sub>2</sub> is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover studyLærke S Gasbjerg, Mikkel B Christensen, Bolette Hartmann, et al.
European Journal of Endocrinology|November 18, 2024
Secretin infusion decreases food intake in healthy men-a randomized, placebo-controlled, double-blind, crossover studySebastian M N Heimbürger, Maria J Bentzen, Hüsün S Kizilkaya, et al.
Diabetologia|April 2, 2017
Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effectSigne Foghsgaard, Louise Vedtofte, Camilla Andreasen, et al.
Diabetes, Obesity & Metabolism|March 2, 2018
Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamerAndreas Brønden, Kristian Mikkelsen, David P Sonne, et al.
European Journal of Endocrinology|June 4, 2021
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controlsAndreas Andersen, Jonatan I Bagger, Maria P A Baldassarre, et al.
Diabetes|May 5, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover StudyNikolaj E Sørum, Julie Warnøe, Jens J Holst, et al.
Diabetes, Obesity & Metabolism|September 7, 2018
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysisDan Siskind, Margaret Hahn, Christoph U Correll, et al.
Cell Reports. Medicine|May 2, 2022
LEAP2 reduces postprandial glucose excursions and <i>ad libitum</i> food intake in healthy menChristoffer A Hagemann, Malene S Jensen, Stephanie Holm, et al.
Pageof 46